2 results
Approved WMOCompleted
Purpose of this investigation is to establish which one of both treatments is most effective in resorption of the calcific deposit in the tendon and diminishing pain.
Approved WMOCompleted
The purpose of this study is to investigate how well a new dosage form of tildrakizumab is tolerated when it is administered to healthy volunteers. Tildrakizumab (also known as Ilumetri) is no new compound; it is already available on the market as a…